Extracorporeal photopheresis as second-line treatment for acute graft-versus-host disease: impact on six-month freedom from treatment failure

Second-line therapy for corticosteroid-refractory or -dependent acute graft-versus-host disease remains ill-defined, due to limited efficacy of drugs and evolving clinical trial endpoints. Six-month freedom from treatment failure has been proposed as a novel clinical trial endpoint and is defined by...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Haematologica
Asıl Yazarlar: Das-Gupta, Emma, Greinix, Hildegard, Jacobs, Ryan, Zhou, Li, Savani, Bipin N., Engelhardt, Brian G., Kassim, Adetola, Worel, Nina, Knobler, Robert, Russell, Nigel, Jagasia, Madan
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Ferrata Storti Foundation 2014
Konular:
Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4222474/
https://ncbi.nlm.nih.gov/pubmed/25150260
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2014.108217
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller